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 Mathematical models are proposed to analyze impedance data on cytotoxicity.
 The models account for both fate and effects of cosmetic ingredients in the system.
 We could describe the cytotoxicity over time of three cosmetic ingredients.
 Models calibrated on acute data failed to predict chronic data.
 In vivo toxicity could be predicted by coupling our models with kinetic model.M
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The ban of animal testing has enhanced the development of new in vitro technologies for cosmetics safety
assessment. Impedance metrics is one such technology which enables monitoring of cell viability in real
time. However, analyzing real time data requires moving from static to dynamic toxicity assessment.
In the present study, we built mechanistic biokinetic/toxicodynamic (BK/TD) models to analyze the
time course of cell viability in cytotoxicity assay using impedance. These models account for the fate of
the tested compounds during the assay.
BK/TDmodels were applied to analyze HepaRG cell viability, after single (48h) and repeated (4 weeks)
exposures to three hepatotoxic compounds (coumarin, isoeugenol and benzophenone-2).
The BK/TD models properly ﬁt the data used for their calibration that was obtained for single or
repeated exposure.
Only for one out of the three compounds, the models calibrated with a single exposure were able to
predict repeated exposure data.
We therefore recommend the use of long-term exposure in vitro data in order to adequately account for
chronic hepatotoxic effects. The models we propose here are capable of being coupled with human
biokinetic models in order to relate dose exposure and human hepatotoxicity.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ting Committee on the Validation of Alternative Methods; ECVAM, European Centre for Validation of Alternative
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Since the 11th of March 2013, with the adoption of the seventh
amendment to the European Union’s Cosmetic (76/768/EEC), the
marketing of cosmetics products tested on animals has been
banned in the European Union. Alternatives to animal testing
methodsmust therefore be developed in order to assess the risks of
cosmetics.
Over the last decades, many in vitro assays have been developed
in the context of replacing animal testing. However, as Adler et al.
(2011) reported, repeated dose toxicity is difﬁcult to predict,
especially based on in vitro data alone, since it results from long-
term repeated exposure to a chemical leading to the deterioration
of cells or organs as a result of their interplay. As discussed in Prieto
et al. (2006), the toxicity of the most affected isolated organ after
repeated exposure can be assessed based on in vitro data provided
relevant in vitro approaches are developed and kinetics is
accounted for through modelling. Since the liver is the organ
most frequently affected by chronic toxicity following repeated
oral exposure to xenobiotics (Bitsch et al., 2006), the priority in the
development of alternatives to repeated dose toxicity testing have
focused on hepatotoxicity.
Although human primary hepatocytes are the gold standard
models for xenobiotic metabolism and toxicity studies (Hewitt
et al., 2007), they have limited life spans and show early
phenotypic changes (Guillouzo, 1998; Guillouzo et al., 1993),
which makes them unsuitable for long-term toxicity tests.
Therefore, differentiated HepaRG cells (Gripon et al., 2002) would
be good candidates for long-term toxicity testing, since they are
stable for 4 weeks (Jossé et al., 2008) and maintain metabolic
activities for 4 weeks (Gerets et al., 2012; Jossé et al., 2008;
Kanebratt and Andersson, 2008). Nevertheless, for metabolism
studies purpose, HepaRG cells and human primary hepatocytes
expressed phase I and phase II enzymes, but at different levels
(Aninat et al., 2006; Anthérieu et al., 2010; Jossé et al., 2008).
Therefore, human primary hepatocytes may still be used for
metabolism study.
Presently, neither ICCVAM nor ECVAM have yet validated any in
vitro repeated toxicity test for systemic effects. However, a wide
range of endpoints can be investigated through the recent
development of in vitro assays such as label-free detection
technologies for cell-based assays for monitoring long-term
toxicity tests.
The ﬁrst real-time, label-free cell substrate impedance sensing
(ECIS) device emerged in 1984 (Giaever and Keese, 1984), allowing
for real-time monitoring of cell dynamics. It was reported to be
able tomonitor cellular events. The system has been improved into
a real-time electronic sensing system (RT-CESTM) using impedance
to monitor cell proliferation, cell spreading (Mitra et al., 1991) and,
more importantly, cell viability (Solly et al., 2004).
With the development of this in vitro label-free cell-based
monitoring system, an alternative to the classical static toxicity
assessment could be considered. Indeed, classically after exposure,
toxicity is evaluated at a predetermined point in time using a static
statistical descriptor such as an EC50 (the concentration at which
there is 50% of the maximal effect) or a NOEC (No Observed Effect
Concentration). This has the disadvantage of not taking into
account the variation of exposure concentration in the system as
well as the time course of toxic effects, which, in contrast, becomes
accessible in real-time data. Therefore, we propose a shift from a
static toxicity assessment to a dynamic one.
In the present study, wemonitored cell viability of HepaRG cells
using impedance metrics. We propose here both the generation of
long- and short-term data by exposing HepaRG cells to three
hepatotoxic cosmetic related compounds, coumarin, isoeugenol
and benzophenone-2 for 48h (single exposure) and 4 weeks(repeated exposure) and the analysis of these data using a
mechanistic model based on systems of ordinary differential
equations which account for the time course of the effect.
We also address the issue of extrapolating from acute to chronic
exposure by assessing the ability of models calibrated using acute
data to predict chronic data. If short term testing could enable the
reliable prediction of long-term in vitro toxicity, this would result
in savings both in terms of time and money.
2. Material and methods
2.1. Cell cultures
Differentiated HepaRG1 cells, purchased from Biopredic
International (Rennes, France), were prepared from cryopreserved
vial stock. Before seeding, an E-plateTM (a 96-well plate designed
for impedance measurement) was coated with type I collagen at
67mg/mL (Rajan et al., 2006), maintained at 37 C for 4h, then
washed with 150mL of Phosphate Buffer Saline solution (PBS,
Gibco1) per well.
HepaRG cells were seeded with 65,000 cells per well in an E-
plateTM with HepaRG Thaw, Seed, and General Purpose supple-
mentTM (Biopredic International, Rennes, France) supplemented
with 100mL Gibco1 William’s E medium, GlutamaxTM (Life
technologiesTM). Cells were maintained at 37 C and 5% CO2 in
an incubator. After 24h, the cells were shifted to the differentiation
medium with 1% DMSO (Sigma1, St., Quentin Fallavier, France)
supplemented with 10 MUI/mL of streptomycin, 10mg/mL of
streptomycin (Life technologiesTM), 10% fetal bovine serum, 100UI/
mL insulin (Eli Lilly, Indianapolis, USA), and 50mM hydrocortisone
(Sigma1, St., Quentin Fallavier, France). The mediumwas renewed
every 2 to 3 days.When impedancemeasurements stabilized, after
checking for cell adhesion and differentiation, which occurred on
around day 7, HepaRG cells were exposed to the compound of
interest.
2.2. Chemicals
The three compounds studied, coumarin (CAS no.: 91-64-5),
isoeugenol (CAS no.: 97-54-1) and benzophenone-2 (2,20,4,40-
tetrahydroxybenzophenone (THB), CAS no.: 131-55-5) were
purchased from Sigma1 (St., Quentin Fallavier, France). The
solubility of the three compounds was checked in DMSO and in
the differentiation medium, with no precipitation visible with the
naked eye and a microscope slide.
Compounds were diluted in culture medium with 1% DMSO in
order to obtain the targeted exposure concentrations while
maintaining phase I and phase II enzyme activity (Aninat et al.,
2006; Anthérieu et al., 2010; Jossé et al., 2008).
In addition, positive and negative controls (with no and high
toxicity expected, respectively) were each monitored with
differentiationmediumwith 1%DMSO and differentiationmedium
with 1% DMSO and 2% sodium-dodecyl-sulfate (SDS).
2.3. Cell exposures
In the short-term experiments, for the three compounds we
tested, HepaRG cells were exposed on a single plate for 48h. The
selected concentrations, based on preliminary range-ﬁnding
experiments were 8; 2.53; 0.8; 0.253; 0.08; 0.025 and
0.008mM, respectively, for the three compounds.
In the long-term experiments, HepaRG cells were exposed for
4 weeks. The mediumwas renewed every 2 to 3 days. The selected
concentrations were 8; 4; 2; 1; 0.5; 0.25; 0.125mM, respectively,
for coumarin and isoeugenol and 4; 2; 1; 0.5; 0.25; 0.125mM for
THB.
Table 1
Metabolic parameters obtained in primary human hepatocytes exposed for 24h to
coumarin at the concentration of 2.5, 5, 10 and 25mM, isoeugenol at the
concentration of 5,10, 25, 50mMand benzophenone-2 at the concentration of 2.5, 5,
10, 25, 50mM. Vmax and Km are respectively the maximum rate of metabolism and
the Michaelis–Menten constant provided by INRA Toxalim (Sophie Antipolis,
France).
Coumarin Isoeugenol Benzophenone-2
Vmax (nmol/min/105 cells) 6.50103 0.295 0.324
Km (mM) 1.6 7.9 34.19
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and three replicates, respectively, were allocated to the positive
controls in the short- and long-term experiments and for the
highest concentration of coumarin and isoeugenol (8mM) in the
long-term exposure experiments; duplicates were allocated for
each nominal concentration and negative control.
2.4. Impedance measurements
Impedance was measured using the xCELLigenceTM system
(ACEA Biosciences, Roche1 Diagnostics). The system measures
electrical impedance across inter-digitated micro-electrodes
placed on the bottom of the 96-well cell culture E-plates1 RTCA.
The impedance measurements were displayed as Cell Index (CI)
(Eq. (1)), which provided quantitative biological information about
the cell population, cyto-morphological changes and viability over
time (Atienza et al., 2005; Ceriotti et al., 2007; Ke et al., 2011; Solly
et al., 2004). The CI was calculated using the following equation:
CI ¼ max
i¼1;:::;N
Rcell f ið Þ
R0 f ið Þ
 1
 
(1)
where N is the number of frequency points at which impedance is
measured, Rcell and R0(fi), respectively, are the frequency-depen-
dent electrode resistance with and without cell at time point t
(wells with 50 to 100mL of PBS) (Solly et al., 2004).
CIs were normalized as described byNawaz et al. (2014). Brieﬂy,
the CI value at time point twas divided by its value at the reference
time point, i.e., the last time before exposure of the compound to
cells. In this way, the normalized cell index (NCI) value was set to
1 at the beginning of exposure. An NCI of 0 means that no cells are
attached to the plates. An increase in the NCI is indicative of
proliferation or spreading of the cells, whereas a decrease of the
NCI is indicative of the detachment or death of the cells (Atienza
et al., 2005; Solly et al., 2004 Xing et al., 2005; Xing et al., 2006). In
the present study, we only considered the decrease in NCI in order
to study the viability of HepaRG cells. A decrease in the NCI
corresponded to a decrease in the cell population in the wells.
2.5. Data analysis
2.5.1. Model description
We proposed mechanistic biokinetics/toxicodynamics (BK/TD)
models to analyze the data. They were based on different
hypotheses regarding the fate of the tested compound in the
system and its effects.
Regarding kinetics, we assumed that it could be described based
on a simple linear one-compartment model described by the
following equation:
dCi
dt
¼ ke  Ce tð Þ  ku  Ci tð Þ
where ke is the cellular elimination rate, ku is the cellular uptake
rate, Ce(t) is the exposure concentration, and Ci(t) is the intra-
cellular concentration. The intra-cellular concentration can be
scaled with ci tð Þ ¼ Ci tð Þ  ke=ku. The scaled intra-cellular concen-
tration then becomes:
dci
dt
¼ ke  Ce tð Þ  ci tð Þð Þ (2)
We tested two hypotheses to account for a possible decrease in
intracellular concentration: (i) a decrease due to unspeciﬁc
binding, such as binding to the plastic or protein and evaporation
phenomena (Eq. (3)), and (ii) a decrease in compoundconcentration due to cell metabolism (Eq. (4)).
dci
dt
¼ k ci (3)
dci
dt
¼ Vmax;estim  ci
Km þ ci
 N
N0
(4)
where k is the unspeciﬁc decrease constant, Vmax,estim the
maximum metabolism rate of HepaRG cell, estimated with the
impedance data, Km the Michaelis Menten constant, N the number
of cell at time point and N0 the number of cells at reference time.
Km was obtained from unpublished metabolism experiments on
human primary hepatocytes performed at INRA Toxalim (Sophia
Antipolis, France). Themetabolism data are summarized in Table 1.
We assumed that the Km values are roughly similar between
human primary hepatocytes and HepaRG cells and that the
differences between the two would be chieﬂy attributable to
metabolic rate.
To analyze cell population viability dynamics, we propose the
following model, which correlated effects to intra-cellular
concentration and accounts for the fact that no cell population
growth is expected for HepaRG, as proposed by Pery et al. (2013):
dN
dt
¼ b ci  NECð Þ  Nifci > NEC (5)
whereN is the number of cells, b the killing rate, ci the intracellular
concentration, and NEC the No Effect Concentration, i.e., threshold
concentration below which there is no signiﬁcant decrease of cell
viability. Thus, as long as the internal concentration is below the
NEC, there is no decrease in N.
We also accounted for the cell spreading phenomenon. Indeed,
according to Xing et al. (2005), an early stage of toxic exposure can
induce transient cellular spreading which leads to a transient
increase in NCI. This phenomenon at subtoxic concentration has
also been described by Solly et al. (2004) for A2780 cells exposed to
an apoptosis-induction regent. Therefore, in addition to Eq. (5), we
added another equation that accounts for transient toxicity-
induced cellular spreading:
dL
dt
¼ g  L0 þ lim ci  NECð Þð Þ  L (6)
where L is the surface of the spreading cells, L0 the initial surface of
the cells, g the spreading rate and lim the spreading coefﬁcient.
2.5.2. Parameter estimation
Calibration was performed using the variation of NCIs between
two consecutive time points instead of NCI values, because we
expected less correlation between successive variations through-
out times compared to successive NCI values measured on the
same population. The variations were weighted by the time
intervals between two measurements. Time intervals were
heterogeneous throughout the experiment. To account for this,
and also to avoid long calculation times during analysis, we
harmonized all considered intervals by considering only measure-
ment times spaced out every 2h and every 4h for respectively
single and repeated exposure. For long-term exposures, we
[(Fig._1)TD$FIG]
Fig.1. Normalized Cell Index (NCI) of HepaRG cells subjected to short-term exposure (48h) ﬁtted by acute BK/TDmodels, for coumarin (A) with a BKmodel due to unspeciﬁc
phenomena (Eq. (3)), for isoeugenol (B) with a BKmodel due to cell metabolism (Eq. (4)), and for benzophenone-2 (C) with a BKmodel due to cell metabolism and a TDmodel
accounting for cell spreading phenomenon. Experimental data and model predictions are represented by points and lines, respectively. In order to improve the clarity of the
ﬁgures, controls are not represented in the present ﬁgure but are shown in the Supplementary data.
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[(Fig._2)TD$FIG]
Fig. 2. Normalized Cell Index (NCI) of HepaRG cells subjected to long-term exposure (every 2 to 3 days) ﬁtted by chronic BK/TDmodels, for coumarin (A) with a BKmodel due
to unspeciﬁc phenomena (Eq. (3)), for isoeugenol (B) with a BK model due to cell metabolism (Eq. (4)), and for benzophenone-2 (C) with a BK model due to cell metabolism
and a TDmodel accounting for the cell spreading phenomenon. Experimental data andmodel predictions are represented bypoints and lines, respectively. In order to improve
the clarity of the ﬁgures, controls are not represented in the present ﬁgure but are shown in the Supplementary data.
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S. Teng et al. / Toxicology Letters 235 (2015) 96–106 101observed an increase of the NCI for roughly 10h after the following
medium renewal. Since it was a reversible increase during less
than 1h, it was considered as an artefact which did not affect the
cytotoxicity. This may also be due to the shortage of certain
medium compounds during the medium renewal. The values in
these intervals were removed from the dataset and from the data
analysis.
We estimated the parameters’ values together with their
conﬁdence intervals using the least squares method. Genoud’s
algorithm of Rgenoud package (Mebane and Sekhon, 2011)
implemented in R software (R Development Core Team, 2013)
was used for the model adjustment. 95% conﬁdence intervals were
calculated through bootstrapping with 1000 re-sampled datasets.
Sampled datasets were built by sampling variations of NCIs
between two time points in each of the replicates.
Once the BK/TD model had been calibrated for each compound
after long- and short- term exposure, we checked the ability of the
acute BK/TD model to predict long-term exposure and, inversely,
the ability of the chronic BK/TD model to predict short-term
exposure.
3. Results
3.1. Cell impedance data
Exposure of HepaRG cells to coumarin and isoeugenol induced a
progressive decrease of NCI values as the tested concentration
increased (Figs. 1 and 2). Regarding NCI of HepaRG cells following
an exposure of 8mM of isoeugenol, it dropped considerably at the
ﬁrst time of measurement after exposure. In contrast to coumarinTable 2
Parameters estimates from acute BK/TD model with different hypotheses relative to ki
Coumarin
Unspeciﬁc mechanisms Cell metabol
k (h-1) 4.05102 –
[3.84102–4.26102]
kmet (mmol/L/h/65,000cells) – 0.283
[0.270–0.294
NEC (mM) 0.445 0
[0.399–0.499] [0–0]
b (L/mmol/h) 6.40103 6.00103
[6.30103–6.5103] [5.90103–
lim – –
g (h1) – –
Sum of squares 0.0137 0.0131
Benzophenon
Unspeciﬁc m
k (h1) 3.70102
[2.11102–
kmet (mmol/L/h/65,000cells) –
NEC (mM) 0.304
[0.248–0.443
b (L/mmol/h) 0.146
[0.136–0.156]
lim 2.37
[1.61–3.30]
g (h1) 0.115
[8.89102–
Sum of squares 0.0480
Parameters estimated with the acute BK/TD models, with k being the elimination rate
estimated no effect concentration (threshold below which there is no effect on cell vi
benzophenone-2 effects inducing transitory cell spreading phenomenon are lim, the cell
to the sum of the squares of the differences between the variations of NCI simulated with
isoeugenol and benzophenone-2 for 48h. Two hypotheses are considered regarding the
exposed cells. The conﬁdence intervals are represented in brackets.and isoeugenol, benzophenone-2 showed a different pattern
depending on the tested concentration. Indeed, for a single
exposure, at the intermediate concentrations of 2.53mM and
0.8mM, a transient increase of NCI was observed.
3.2. BK/TD model after short-term exposure
Regarding the toxicodynamic component of the BK/TD model,
for coumarin and isoeugenol, the cell viability was described with
Eq. (5). For the third compound, benzophenone-2, we also had to
account for the transient cell spreading phenomenon with Eq. (6).
For all compounds, the best ﬁts were obtained with very rapid
kinetics (Instead of Eq. (2), internal concentration was thus
assumed to equal exposure concentration).
For all compounds, wewere not able to distinguish between the
two fate models, either with a decrease due to an unspeciﬁc
mechanism (Eq. (3)) or cell metabolism (Eq. (4)), only based on
goodness of ﬁt (GOF) (Table 2). Coumarin’s and isoeugenol’s NEC
estimated by the model with a metabolism decrease were close to
zero, whereas the NEC estimated by themodel with a decrease due
to unspeciﬁc mechanisms were not (i.e., 0.445mM for coumarin
and 0.33mM for isoeugenol). For benzophenone-2, both fate
models, unspeciﬁc mechanism and metabolism, provided similar
NEC value estimates (Table 2).
3.3. BK/TD model after long-term exposure
For two compounds, coumarin and benzophenone-2, there
were differences in GOF depending on the selected fate model. For
coumarin, the model with a decrease due to unspeciﬁcnetics.
Isoeugenol
ism Unspeciﬁc mechanisms Cell metabolism
4.92102 –
[4.64102–5.17102]
– 0.113
] [0.108–0.116]
0.330 500104
[0.277–0.404] [0–7.14102]
1.60102 1.32102
6.10103] [1.51102–1.71102] [1.27102–1.41102]
– –
– –
0.0098 0.0098
e-2
echanisms Cell metabolism
–
5.12102]
3.43102
[2.12102–4.04102]
0.294
] [0.234–0.438]
0.140
[0.131–0.151]
2.50
[1.94–3.40]
0.100
0.156] [7.72102–0.130]
0.0485
of the compound due to unspeciﬁc mechanisms, kmet the metabolic rate, NEC the
ability), b the killing rate by the compound. Coefﬁcients relative to early stage of
spreading coefﬁcient and g the cell-spreading rate. The sum of squares corresponds
the model and observed the variations of NCI of HepaRG cells exposed to coumarin,
decrease of exposure concentration: unspeciﬁc mechanisms or metabolism by the
Table 3
Parametric estimates from chronic BK/TD model with different hypotheses regarding kinetics.
Coumarin Isoeugenol
Unspeciﬁc mechanisms Cell metabolism Unspeciﬁc mechanisms Cell metabolism
k (h1) 5.15102 – 4.59102 –
[4.94102–5.21102] [4.16102–9.34102]
kmet (mmol/L/h/65103 cells) – 0.113 – 9.08102
[0.107–0.118] [6.19102–0.103]
NEC (mM) 0.147 0 0.305 0.216
[0.104–0.150] [0–0] [5.23102–0.331] [0–0.292]
b 6.90103 3.50103 4.28102 4.08102
[6.50103–7.40103] [3.3103–3.7103] [1.78102–5102] [1.59102–5.02102]
lim – – – –
g (h1) – – – –
Sum of squares 0.0132 0.0146 0.0102 0.0108
Benzophenone-2
Unspeciﬁc mechanisms Cell metabolism
k (h1) 1.04102 –
[9.00103–1.18102]
kmet (mmol/L/h/65103 cells) – 2.51102
[2.16102–2.82102]
NEC (mM) 0.404 0.272
[0.395–0.414] [0.256–0.291]
b 0.177 0.162
[0.173–0.182] [0.158–0.167]
lim 2.370* 2.496*
g (h1) 0.115* 0.100*
Sum of squares 0.0126 0.0110
Parameters estimated with the chronic BK/TD models, with k being the elimination rate of the compound due to unspeciﬁc mechanisms, kmet the metabolism rate, NEC the
estimated no effect concentration (threshold below which there is no effect on cell viability), b the killing rate by the compound. Coefﬁcients relating to an early stage of
benzophenone-2 effects inducing transitory cell spreading phenomenon are lim, the cell spreading coefﬁcient and g the cell-spreading rate. The sum of squares corresponds
to the sum of the squares of the differences between the variations of NCI simulated with the model and observed variations of NCI of HepaRG cells exposed to coumarin,
isoeugenol and benzophenone-2 repeatedly every 2 to 3 days for 4 weeks. Two hypotheses are considered regarding the decrease of exposure concentration: unspeciﬁc
mechanisms or metabolism by the exposed cells. The conﬁdence intervals are represented in brackets.
* corresponds to the value of the parameter estimated by the acute model.
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compared to the model with a decrease of concentration of
exposure due to cell metabolism. The NEC estimated by the model
with a decrease due to unspeciﬁc mechanisms was of 0.147mM,
whereas themodel with a decrease due tometabolism estimated it
at 0mM.
Regarding the benzophenone-2 BK/TD model, the spreading-
related parameters could not be estimated with the long-term
exposure data. Therefore, lim, the cell spreading coefﬁcient, and
g , the cell spreading rate, were ﬁxed to the values estimated
with short-term exposure. The model with a decrease of
exposure concentration due to cell metabolism better described
the repeated exposure data than the model with a decrease due
to a unspeciﬁc mechanism, based on GOF (Table 3 and Fig. 2).
Unlike for these two compounds, there was no difference in
terms of GOF between the two kinetic models for isoeugenol.
3.4. Predictivity of acute and chronic BK/TD models of respectively
repeated exposure and single exposure data
Once the models for the three compounds were calibrated
based on the acute data, we simulated their predictions for
repeated exposure. Except for coumarin, the acute BK/TD model
(i.e., isoeugenol and benzophenone-2) over-predicted NCI at
intermediate concentration of 2mM for isoeugenol and 0.5mM
for benzophenone-2 (Fig. 3). Coumarin’s acute BK/TD model did
quite well in predicting the time course of the NCI at different
concentration of exposure, as shown by Fig. 3.
The models calibrated with chronic exposure data, except for
coumarin, were not able to predict the short-term exposure data,especially at the intermediate concentrations of 2.53mM for
isoeugenol and 0.8mM of benzophenone-2 (Supplementary
data).
4. Discussion
We proposed here BK/TD models to describe the time
course of the viability of cell populations exposed to cosmetic
ingredients, thanks to impedance metric measurements. Al-
though unspeciﬁc decrease and cellular metabolism could both
inﬂuence the fate of the tested compounds, we assumed that one
mechanism was predominant relative to the other. We would not
be able to estimate the parameters if both phenomena were
considered simultaneously in the model since it would require
having kinetic data of the compounds (i.e., free concentrations
measurements over time or metabolism data on the tested
HepaRG cells).
Depending on the selected fate model, the estimates of
toxicity parameters (NEC and b) differed substantially (Table 2).
It is therefore necessary to be able to select the most realistic
model for a relevant application in performing a risk assess-
ment. It was not possible to identify the most accurate models
solely on the basis of the GOF of the impedance data (Table 2).
Therefore, complementary experimental data are required,
particularly in relation to metabolism. Fortunately, such
information was available from other experiments (unpublished
at the moment) performed at INRA Toxalim. Human primary
hepatocytes were exposed to the three compounds we studied
here in order to measure metabolism. Coumarin’s maximum
velocity (Vmax) on human hepatocytes was 0.0065nmol/min/105
[(Fig._3)TD$FIG]
Fig. 3. Prediction of the Normalized Cell Index (NCI) of HepaRG cells after long-term exposure (every 2–3 days for 4 weeks) based on acute BK/TD models. Predictions were
performed for coumarin (A) with a TK model due to unspeciﬁc phenomena (Eq. (3)), for isoeugenol (B) with a TK model due to cell metabolism (Eq. (4)), and for
benzophenone-2 (C) with a TK model due to cell metabolism and a TD model accounting for the cell spreading phenomenon (Eq. (6)). Experimental data and predictions by
the acutemodels are respectively represented by differently shaped points and lines. In order to improve the clarity of the ﬁgures, controls are not represented in the present
ﬁgure but are shown in the Supplementary data.
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rate (Vmax) equal to 0.0025mmol/L/h/65.103 cells. This value is
far below the value estimated by our BK/TD model with
metabolism to account for the decrease of exposure concentra-
tion (0.283mmol/L/h/65.103cells). Thus, the decrease of couma-
rin concentration is unlikely to be related to metabolism, and
the model of a decrease of coumarin concentration due to an
unspeciﬁc phenomenon (Eq. (3)) should be selected.
Metabolism experiments on human primary hepatocytes
exposed to isoeugenol and benzophenone-2 showed cell metabo-
lism for these compounds with Vmax values of 0.295nmol/min/105
cells and 0.324nmol/min/105 cells, respectively. According to the
metabolism rate (Vmax,estim) estimated by our acute BK/TD model
for isoeugenol and benzophenone-2 in HepaRG cells and their
experimental Michaelis–Menten constant (Km) (Vmax,estim of
0.113mmol/L/h for 65.103 cells and 0.0343mmol/L/h for 65.103
cells and Km of 7.9mM and 34.19mM respectively), their respective
maximum of velocity (Vmax) after a single exposure would be
0.290nmol/min/105 cells and 0.0879nmol/min/105 cells. The
metabolism rate of benzophenone-2 and isoeugenol we estimated
with our BK/TDmodels were thus equivalent or only 4 times lower
in HepaRG cells than in human primary hepatocytes (Table 1),
which suggests that metabolism is a likely explanation for the
decrease of exposure concentration of isoeugenol and THB. This
also indicates that HepaRG cells metabolism for these two
compounds is comparable to primary hepatocytes, even in the
presence of DMSO to maintain the cells in the differentiated state.
This is consistent with literature data, since benzophenone-2 and
isoeugenol have been reported to be metabolized by phase II
enzymes (Badger et al., 2002; Hong et al., 2013) via sulfo or
glucurono conjugation. Some phase II enzymes, especially some
sulfotransferases and UDP-glucuronyltransferases, are reported to
be expressed at a lower level in HepaRG cells compared to human
primary hepatocytes (Hart et al., 2010; Kanebratt and Andersson,
2008).
Regarding the toxicodynamics model, the cell viability of the
three compounds was modelled using a simple equation based on
a decrease in cell population (Eq. (5)). For one of the studied
compounds, benzophenone-2, we had to add to the toxicody-
namics model an equation (Eq. (6)) that accounted for a transitory
spreading cells phenomenon due to an early-stage reversible toxic
effect (Solly et al., 2004). This made it possible to adequately
account for the toxicity phenomena leading to a decrease in cell
population.
Our estimate of NEC from acute exposure to coumarin is
consistent with the literature data on cytotoxicity for this
compound. No cytotoxicity was observed below 0.2mM of
Coumarin exposure on human hepatocytes for 24h or 72h
(Kienhuis et al., 2006; Ratanasavanh et al., 1996). We did not ﬁnd
cytotoxicity data on isoeugenol and benzophenone-2 or on
coumarin after chronic exposure in the literature to compare
with the threshold concentrations we estimated in our study.
Simulations of single exposure by the chronic BK/TD model
showed that the chronic BK/TD models of isoeugenol and
benzophenone-2 were not able to accurately predict the time
course of cell viability after a single exposure at intermediate
concentrations (2.53mM for isoeugenol and 0.8mM for benzo-
phenone-2 (Supplementary data). Based on modelling, this is
suggestive of different toxicological phenomena for acute and
chronic exposure andmeans that acute and chronic data have to be
analysed separately. Note, however, that in the case of benzophe-
none-2, in order to fully understand its toxicity, acute data were
required to explain cells’ spreading in addition to chronic toxicity
data. Long-term cytotoxicity results from complex interactions
with multiples pathways, than cannot be assessed only with
impedance data. Further in-depth investigations on the cellularbiological interactions, involving other measurements than
impedance, would thus be needed.
The inability of the acute BK/TD models to predict chronic data
might be due to a loss of some cellular mechanism of defence after
chronic exposure. When exposed to a xenobiotic, the cellular
response can either be a reversible adaptive response to a
chemical-induced stress, which usually occurs at subtoxic
exposures, or it can produce a disruption of homeostasis, leading
to an irreversible decrease of cellular responsewhich compromises
cell viability (Martindale and Holbrook, 2002; Williams and
Iatropoulos, 2002). Nevertheless, exposure which induces an
adaptive response canproduce toxicitywith either longer or higher
exposure (Williams and Iatropoulos, 2002). The drastic drop in NCI
inHepaRG cells after the fourth exposure (Fig. 3) of benzophenone-
2 and after the second exposure of isoeugenol at the respective
subtoxic concentrations of 0.5mM and 2mM resulted from subtler
changes that cannot be observed with impedance metrics. This
decrease could be a consequence of an overwhelming phenome-
non of the adaptive cellular response.
Another hypothesis for explaining the drastic drops of 2mM for
isoeugenol and 0.5mM for benzophenone-2 would be a decrease
of cell metabolic capacity after repeated exposures at these
concentrations. This decrease in metabolism would indeed result
in a higher exposure concentration over time.
The simulations with the coumarin acute BK/TD model for
repeated exposure did well in predicting the experimental chronic
(i.e., long-term exposure) data (Fig. 3). Unlike isoeugenol and
benzophenone-2, no additional or different mechanism for long-
term exposure compared to short-term exposure of HepaRG cell to
coumarin has been shown.
The models we proposed in the present study make it possible
to monitor and, in ﬁne, to predict real-time cell viability, but they
are limited to cytotoxicity and do not address, for instance, cell
speciﬁc function loss. Cytotoxicity assay has been validated as cell-
based method to estimate starting doses for acute oral systemic
toxicity tests (OECD, 2010; Prieto et al., 2014) and to identify
negative oral toxicity for non-classiﬁed substances (Prieto et al.,
2014). However, in vivo toxicity induced by exposure to chemicals
involves several complex interactions at different scale e.g., multi-
pathways, multi-cellular, multi organ. Observed toxicity may
results in modiﬁcations of physiological homeoastasis leading to
functional alterations at different scales and more particularly at
cellular scale. Quantifying and analyzing mechanisms of cellular
function loss is still challenging.
In vivo-in vitro extrapolation (IVIVE) can be performed using our
models to contribute to the prediction of in vivo hepatotoxicity
under the hypothesis that effects on hepatic cell viability could be
indicative of potential hepatotoxicity. Usually risk assessment in
humans is based on data extrapolated from animals. As Prieto et al.
(2006) pointed out, this approach is not based on scientiﬁc
evidence, and additional data on the mechanism of animal and
human toxic effects are needed. With the ban of animal testing in
cosmetic ingredients, in vitro techniques and IVIVE methods are
required. One of the hopes is that mechanistic information gained
from in vitro techniques would partly compensate for not using full
organisms.
In vitro-in vivo extrapolation is based on models accounting for
toxicodynamics and biokinetics. The different phases of absorption
– distribution – metabolism – excretion (ADME) can be predicted
using physiology-based biokinetic (PBBK) models. These models
represent the organism as a series of relevant compartments of
organs or groups of similar organs linked by physiological blood
ﬂow. Coupling in vitroTDmodelwith PBBKmodels (called PBBK/TD
models) to relate hepatic concentration to the dynamic model can
be used to extrapolate in vitro cytotoxicity on hepatic cells to in vivo
hepatotoxicity. Using reverse dosimetry, PBBK/TD models would
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that (i) in vitro toxicity data reﬂects the relevant toxicity
parameters for in vivo situation, (ii) the appropriate parameters
for building an adequate PBBK model are available (Blaauboer
et al., 2012). Pery et al. (2013) have already showed that such
approach is feasible by using IVIVE to estimate a human in vivo
threshold dose of acetaminophen, which appeared to be closed to
the usual range of human overdose, can be estimated. Such an
estimated threshold could also account for the variability between
different sub-populations, at least regarding kinetics, with
different physiological characteristics such as age, renal insufﬁ-
ciency, polymorphisms and adapt risk assessment to targeted
populations.
As ECVAM has highlighted in their report and recommenda-
tion of ECVAMWorkshop 56, only a few attempts have beenmade
to obtain toxicological data from long-term exposure of cells to a
xenobiotic (Pfaller et al., 2001). Among these few attempts, the EU
7th Framework project, Predict-iv has been conducted to improve
the predictivity of in vitro systems by developing mechanistic
strategies. Thus, within this project, datasets have been generated
in order to investigate long term repeated dose toxicity in three
targeted organs (i.e., the liver, the kidney and the central nervous
system), and a mechanism-based model of cellular toxicity has
been developed for renal epithelial cells (RPTEC/TERT1) exposed
repeatedly for 14 days to the nephrotoxin cyclosporine A (Wilmes
et al., 2013). In the present study, we proposed an approach
providing long-term, real-time toxicological data using impedance
metrics and also a methodology for analyzing these data. Due to
the cost of long-term toxicity testing, we also addressed the issue
of using acute toxicity data to extrapolate to chronic toxicity data.
Through our study, we showed that acute-to-chronic extrapola-
tion might lead to inaccurate predictions of chronic toxicity.
The proposed models to describe the cell viability decrease
exposed to the different compounds, depending on the models,
with three to ﬁve parameters, were able to reasonably describe the
data. Nevertheless, additional metabolism data such as metabolite
concentration measurements would be required to select the BK
model that should be used for hazard assessment.
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